Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities
3.12.2025 13:30:00 CET | Business Wire | Press Release
Cencora, a global pharmaceutical solutions company, today announced investments to enhance its third-party logistics (3PL) capabilities in the United States and Europe, expanding its global network and strengthening the specialty logistics services it can deliver to pharmaceutical companies worldwide.
As more specialty pharmaceuticals reach the market and the demand for comprehensive drug supply management continues to increase, Cencora is enhancing its global 3PL services offering by:
- Increasing capabilities in key markets in Europe: Cencora is expanding its pan-European logistics capabilities through the addition of NextPharma Logistics, a healthcare logistics provider that delivers services across Germany, Austria and Switzerland. Cencora also will open a 3PL facility in Italy in 2026, building on recent investments to expand storage capacity in France, Spain and the UK.
- Expanding storage capacity, cold chain capabilities in the United States: Cencora plans to open a new, highly automated 500,000 square-foot 3PL facility in Texas in 2028.
“Our customers trust us to serve as an extension of their operations. We continue to strengthen our pharmaceutical logistics capabilities through investments across our 3PL network to deliver enhanced support tailored to their needs,” said Chris Williams, Senior Vice President and President of Alloga Europe & ICS. “Whether it’s a large-scale global program or supporting the launch of an advanced therapy in a new market, we’re able to provide the integrated support our customers need to navigate supply chain complexities, maximize commercial success and ensure efficient and reliable access to their products.”
Enhanced Pan-European 3PL capabilities
Headquartered in Germany, NextPharma Logistics offers integrated supply chain solutions, such as storage, distribution, serialization and quality assurance and compliance management. The company offers temperature-controlled solutions, including refrigerated and deep-frozen storage, through its Good Distribution Practice (GDP)-compliant facilities in Germany, Austria and Switzerland.
The addition of NextPharma Logistics and planned opening of a 3PL facility in Italy increases Cencora’s logistics capabilities in key markets in Europe, enabling the company to deliver more comprehensive pan-European support. Cencora is further strengthening its specialty logistics capabilities in Europe by expanding cold chain capacity across its network, including developing a dedicated specialty unit equipped with cryogenic technology in the Netherlands and increasing refrigerated and frozen storage capacity in France.
“Pharmaceutical companies increasingly seek partners that can provide comprehensive support across multiple markets,” said Alina Chesnokova, Vice President, Global 3PL Commercialization, Cencora. “Through our internationally scaled 3PL service and suite of commercialization solutions, Cencora is uniquely positioned to support their needs, delivering integrated support to enable seamless expansion into new markets and ensure products are delivered on time and in the right condition.”
Expanded capacity, cold chain capabilities in the United States
Cencora plans to open a 500,000 square-foot 3PL facility in Texas, which is expected to be fully operational in 2028. The new site — Cencora’s fifth 3PL facility in the United States — will significantly increase Cencora’s capacity to store products at controlled room temperature, refrigerated and frozen ranges, including ultra-low and cryogenic.
In addition to the facility in Texas, Cencora has more than tripled its ultra-low and cryogenic storage capacity across its 3PL network in the United States to support the increasing number of specialty medicines, such as cell and gene therapies. The expanded storage capacity, coupled with Cencora’s global specialty logistics capabilities, enables the company to provide comprehensive logistics support from clinical trials through commercialization, including a supply chain solution designed for cell and gene therapies.
For more information about Cencora’s comprehensive 3PL services, please visit: Cencora.com/logistics/3PL
About Cencora
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 51,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #18 on the Global Fortune 500 with more than $300 billion in annual revenue.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251202258954/en/
Contacts
Media:
Mike Iorfino
mike.iorfino@cencora.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Iconic Landmark Danjiang Bridge Opened to Redefine Taiwan18.5.2026 12:02:00 CEST | Press Release
The Danjiang Bridge, one of Taiwan’s most significant recent public infrastructure projects, officially opened with a series of large-scale public events, transforming the bridge into a new cultural landmark and civic space. The program featured the “Danjiang Bridge Together Arts Festival,” immersive public activities, and a special performance of Light Chain by Cloud Gate Dance Theatre, symbolizing the integration of architecture, engineering, and the arts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260517667930/en/ The Danjiang Bridge is an iconic landmark in Taiwan with global recognition. (Photo via Highway Bureau , Motc) Spanning the mouth of the Tamsui River, the bridge serves as both a major transportation project and a recognizable architectural landmark, establishing a new urban symbol for Taiwan. Designed by Zaha Hadid Architects, the project gained international attention throughout its development and was sel
Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy18.5.2026 09:00:00 CEST | Press Release
Prokarium, a clinical-stage biopharmaceutical company pioneering bacterial immunotherapies for the treatment of solid tumours, today announced safety and antitumour efficacy results from an interim review of the ongoing Phase 1/1b PARADIGM-1 trial of ZH9 in non-muscle invasive bladder cancer (NMIBC) patients. These data were shared via an oral podium presentation at the American Urology Association (AUA26) Annual Meeting. Prokarium CMO, Dr Josefin-Beate Holz said “These data demonstrate ZH9 as a universally applicable treatment for patients. As the treatment is very well tolerated and is showing impactful outcomes for early and BCG-non-responsive patients alike, it opens up the potential for ZH9 to be a transformative bladder saving treatment.” "There is a clear and urgent need to move beyond BCG. The current treatment burden—requiring up to 18 catheterisations in the first year— detrimentally impacts real-world compliance and patient outcomes," said Ibs Mahmood, CEO of Prokarium. "Pat
OdysseyRe Announces New Co-Chief Underwriting Officers for EMEA18.5.2026 09:00:00 CEST | Press Release
Odyssey Reinsurance Company (OdysseyRe) today announced the appointments of Tegwen Gromellon and Anne-Claire Serres as co-chief underwriting officers of its EMEA division, effective July 1. They succeed longtime Chief Underwriting Officer, Gaël Le Païh, who is retiring later this year following 36 years with the Company. Based in Paris, Serres joined OdysseyRe in 2018 as the market director for France and will lead the division’s business across France, Africa and the Middle East. Gromellon, who joined OdysseyRe in 2004, has served as market director for Germany, Austria, Benelux and Switzerland since 2019. He will take the lead for the rest of Europe, including the relationship with the Company’s representative office in Stockholm for the Nordic markets and across Turkey. “We are delighted to appoint both Tegwen and Anne-Claire to these important leadership positions,” said Isabelle Dubots-Lafitte, chief executive officer of EMEA for OdysseyRe. “These appointments recognize their sign
Arboris Capital Selects ROYC to Expand Private Markets Capabilities on CapGain Platform18.5.2026 09:00:00 CEST | Press Release
Arboris Capital Limited (“Arboris”), a DIFC-based firm arranging alternative investments, authorised by the Dubai Financial Services Authority (DFSA), today announced that it has selected ROYC AB (“ROYC”), a private markets technology and infrastructure provider, to support the continued development of its private markets offering through its platform, CapGain. In its ongoing efforts to expand its private markets capabilities across the Middle East, Arboris has undertaken a strategic review of how to further scale its offering while maintaining the integrity of its existing platform. As a result, Arboris has chosen to integrate ROYC’s fund access, sourcing, and structuring capabilities into CapGain, complementing its existing infrastructure. CapGain is Arboris’s proprietary investment platform, purpose-built to facilitate access between international private market opportunities and Professional Investors in the region. CapGain provides fully digital investor onboarding and KYC, a secu
LogicMonitor and Deutsche Telekom Expand Partnership Across Europe18.5.2026 09:00:00 CEST | Press Release
LogicMonitor®, the AI-first platform for Autonomous IT, today announced the expanded availability of its platform within Deutsche Telekom’s managed services portfolio across selected European markets, including DACH, Benelux, and the Nordics. The expansion builds on operational use of LogicMonitor in the United Kingdom since 2023, where it has supported Deutsche Telekom’s service teams in improving visibility across network, cloud, and hybrid infrastructure environments. Experience gained from these deployments is now informing broader service enablement across additional European markets. As enterprise IT environments grow more complex, organisations require more than visibility—they need predictive resilience. Through defined use cases, LogicMonitor complements Deutsche Telekom’s existing service management, monitoring, and security tooling, helping teams anticipate, detect, and resolve issues before they impact business operations. In the United Kingdom, the partnership has delivere
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom